HIGHLIGHTS
SUMMARY
Approximately 17% of hematological cancer patients have suffered clinical anxiety and/or depression during treatment with diagnosis (Clinton-McHarg et_al, 2014; Posluszny et_al, 2019). Many studies have focused on mixed groups of hematological cancer survivors rather than specific survivors (Hall et_al, 2013a,b, 2014; El-Jawahri et_al, 2020). Five years after the diagnosis of myeloma patients, about 27.4% of patients reported signs of anxiety and 25.2% reported signs of depression (Molassiotis et_al, 2011; Lamers et_al, 2013; Copeland et_al, 2017). Pain is one of the most common somatic symptoms with MM during maintenance . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.